PMID- 31586136 OWN - NLM STAT- MEDLINE DCOM- 20201111 LR - 20210110 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 9 IP - 1 DP - 2019 Oct 4 TI - Sex differences in risk factors for stroke in patients with hypertension and hyperhomocysteinemia. PG - 14313 LID - 10.1038/s41598-019-50856-z [doi] LID - 14313 AB - Data on the sex-specific differences in risk of stroke among patients with H-type hypertension are limited. We aimed to analyze interactions between sex and other risk factors on stroke, including the sex-methylenetetrahydrofolate reductase (MTHFR) interaction. A retrospective analysis of baseline data from 2040 patients with hypertension and hyperhomocysteinemia (HHcy) included demographic characteristics, biomarkers, history of chronic diseases and lifestyle factors. Polymerase chain reaction-restriction fragment length polymorphism method was used to investigate the C677T polymorphism of MTHFR gene. We examined independent effects and interactions between sex and stratified factors on the risk of stroke by logistic regression model. A total of 1412 patients suffered stroke, and the prevalence of stroke was 70.65% in men and 66.53% in women. Both men and women had independent risk factors for stroke, including diabetes mellitus, atrial fibrillation, smoking, increased level of systolic blood pressure (SBP) and plasma total homocysteine (tHcy), as well as the decreased level of high-density lipoprotein cholesterol. Diastolic blood pressure (DBP) -specific risk of stroke was unique to men. Interactions between sex and other risk factors on stroke risk were statistically significant: age, fasting plasma glucose (FPG), SBP, DBP, triglycerides (TG) and tHcy. Furthermore, tHcy interacted with age, SBP and DBP in men, and age, SBP, DBP, FPG, and TG in women to modulate the risk of stroke. Although TT genotype did not have an independent effect on stroke, it could interact with sex and FPG, TG and SBP to increase stroke. In conclusion, sex-specific differences are useful to stratify the risk of stroke and assist clinicians in the decision to select a reasonable therapeutic option for high-risk patients. FAU - Pang, Hui AU - Pang H AD - Department of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, Jiangsu, China. phui81@126.com. FAU - Fu, Qiang AU - Fu Q AD - Department of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, Jiangsu, China. FAU - Cao, Qiumei AU - Cao Q AD - Department of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, Jiangsu, China. FAU - Hao, Lin AU - Hao L AD - Department of Urinary Surgery, Xuzhou Central Hospital, Xuzhou, Jiangsu, China. FAU - Zong, Zhenkun AU - Zong Z AD - Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. zongzhenkun2009@126.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20191004 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - EC 1.5.1.20 (MTHFR protein, human) RN - EC 1.5.1.20 (Methylenetetrahydrofolate Reductase (NADPH2)) SB - IM MH - Aged MH - China/epidemiology MH - Female MH - Humans MH - Hyperhomocysteinemia/*epidemiology MH - Hypertension/*epidemiology MH - Male MH - Methylenetetrahydrofolate Reductase (NADPH2)/genetics MH - Middle Aged MH - Polymorphism, Genetic MH - Prevalence MH - Retrospective Studies MH - Risk Factors MH - *Sex Factors MH - Stroke/*epidemiology PMC - PMC6778198 COIS- The authors declare no competing interests. EDAT- 2019/10/06 06:00 MHDA- 2020/11/12 06:00 PMCR- 2019/10/04 CRDT- 2019/10/06 06:00 PHST- 2019/03/29 00:00 [received] PHST- 2019/09/20 00:00 [accepted] PHST- 2019/10/06 06:00 [entrez] PHST- 2019/10/06 06:00 [pubmed] PHST- 2020/11/12 06:00 [medline] PHST- 2019/10/04 00:00 [pmc-release] AID - 10.1038/s41598-019-50856-z [pii] AID - 50856 [pii] AID - 10.1038/s41598-019-50856-z [doi] PST - epublish SO - Sci Rep. 2019 Oct 4;9(1):14313. doi: 10.1038/s41598-019-50856-z.